 region chang creatin kinas myocyt size hypertens nonhypertens cardiac hypertrophi sever intracellular enzym total activ isoenzym composit cardiac hypertrophi studi hypothesi accumul fetal-typ BB MB creatin kinas CK hypertrophi adult myocardium increas blood pressur consider locat size hemodynam load myocyt two-kidney one-clip rat model renal hypertens hydralazin treatment CK total isoenzym lactat dehydrogenas synthas activ myocyt size increas heart weight/bodi ratio untreat rat hydralazine-tr rat control rat blood pressur high untreat rat mm Hg hydralazine-tr rat mm Hg control rat mm Hg myocyt ventricular region ventricular epicardi endocardi free wall right halv interventricular septum ventricular free wall region differ normal hypertrophi myocardium morpholog biochem paramet chang left ventricular endocardium shift CK isoenzym express BB MB hypertens hypertrophi untreat rat nonhypertens hypertrophi hydralazine-tr rat isol myocyt volum cellular content total CK hypertroph process decreas tissu activ measur lactat dehydrogenas citrat synthas activ myocardium glycolyt capac effect presenc high blood pressur blood pressur fetal CK isoenzym shift hypertrophi